Stryker Corporation (SYK) : Analyst Rating Update

Stryker Corporation (SYK) : The consensus on Stryker Corporation (SYK) based on 24 analyst recommendation on the company stock is 1.9, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 14 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 6 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 2 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.

Stryker Corporation (SYK) : Currently there are 18 street experts covering Stryker Corporation (SYK) stock. The most bullish and bearish price target for the stock is $134 and $88 respectively for the short term. The average price target of all the analysts comes to $118.28. The estimated standard deviation from the target is $10.19.

Stryker Corporation (NYSE:SYK): The stock opened at $120.58 on Wednesday but the bulls could not build on the opening and the stock topped out at $121.42 for the day. The stock traded down to $120.32 during the day, due to lack of any buying support eventually closed down at $121.09 with a loss of -0.10% for the day. The stock had closed at $121.21 on the previous day. The total traded volume was 1,499,467 shares.

Also, Guggenheim Securities initiates coverage on Stryker Corporation (NYSE:SYK). The rating major has initiated the coverage with buy rating on the shares. The rating by the firm was issued on June 9, 2016. The company shares have rallied 27.03% from its 1 Year high price. On Jul 5, 2016, the shares registered one year high at $121.60 and the one year low was seen on Jan 11, 2016. The 50-Day Moving Average price is $114.25 and the 200 Day Moving Average price is recorded at $104.88.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.